コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 is a prospective observational study in very preterm infants.
2 ds) in preventing CMV transmission via BM in preterm infants.
3 he spectrum of injury and abnormal growth in preterm infants.
4 , a main cause of mortality and morbidity in preterm infants.
5 edicting neurodevelopmental outcomes in very preterm infants.
6 may cause long-term adverse effects in very preterm infants.
7 ocolitis (NEC) and feeding intolerance among preterm infants.
8 d individualized care to enhance outcomes in preterm infants.
9 igh bronchopulmonary dysplasia (BPD) risk in preterm infants.
10 otizing enterocolitis, a severe pathology in preterm infants.
11 le is known about the microglial response in preterm infants.
12 spiratory and neurodevelopmental outcomes in preterm infants.
13 ties and faecal samples from healthy and ill preterm infants.
14 rum levels of IL-5 and IL-13 but not IL-4 in preterm infants.
15 to improve rates of successful extubation in preterm infants.
16 e births was 1.48; 0.76 in term and 15.52 in preterm infants.
17 timodal brain MRI to study a large cohort of preterm infants.
18 ll children with cerebral palsy, but not for preterm infants.
19 rican and European-American low-birth-weight preterm infants.
20 cluding bronchopulmonary dysplasia (BPD), in preterm infants.
21 develop respiratory distress syndrome among preterm infants.
22 and late preterm (MLPT) births comprise most preterm infants.
23 for prevention of allergic diseases in very preterm infants.
24 l vasculature, eye, and brain development of preterm infants.
25 terval and survival and morbidity among very preterm infants.
26 mental safety of hydrocortisone in extremely preterm infants.
27 eading and intractable cause of mortality in preterm infants.
28 plementation in predominantly human milk-fed preterm infants.
29 g enterocolitis and late-onset sepis in very preterm infants.
30 terocolitis, late-onset sepsis, and death in preterm infants.
31 r neurodevelopmental impairment in extremely preterm infants.
32 novel strategy for the prevention of BPD in preterm infants.
33 guidelines exist for the nutritional care of preterm infants.
34 t of bronchopulmonary dysplasia in extremely preterm infants.
35 useful therapeutically to alleviate FIRS in preterm infants.
36 cohort study of consecutively born extremely preterm infants.
37 table for monitoring the postnatal growth of preterm infants.
38 AMPA receptors in autopsy samples from human preterm infants.
39 ate preterm") infants, the largest cohort of preterm infants.
40 near term, have not been studied among very preterm infants.
41 patent ductus arteriosus (PDA) in extremely preterm infants.
42 nalyzed data from 63 trials involving 15,712 preterm infants.
43 r) outcomes at 2 years corrected age in very preterm infants.
44 inical intervention to support the growth of preterm infants.
45 factors has promise as a therapy for BPD in preterm infants.
46 mprove long-term cardiopulmonary outcomes in preterm infants.
47 ty)-for prediction of motor outcomes in very preterm infants.
48 predictive references for weight centiles of preterm infants.
49 and validated the pre-trained model using 33 preterm infants.
50 be sufficient to protect extremely and very preterm infants.
51 on development of allergic diseases in very preterm infants.
52 and fortified PDHM intended for nutrition of preterm infants.
53 entions to improve clinical outcomes in very preterm infants.
54 placebo throughout the RSV season in healthy preterm infants.
55 (death within the first 28 days of life) in preterm infants.
56 s and even death, yet BM is advantageous for preterm infants.
57 nal supplement for preventing retinopathy in preterm infants.
58 ciated with aortic intima-media thickness in preterm infants [1.0 um (95% CI: 0.2, 1.8) per week of e
59 RNA gene sequencing.Among the 3161 enrolled preterm infants, 106 (3.4%; 95% CI: 2.8%, 4.0%) develope
61 owing themes: 1) nutrient specifications for preterm infants, 2) clinical and practical issues in ent
62 edical Birth Register, we identified 113,300 preterm infants (22 weeks 0 days to 36 weeks 6 days of g
63 l and practical issues in enteral feeding of preterm infants, 3) gastrointestinal and surgical issues
69 After the primary series, the proportion of preterm infants across all gestational age groups who ac
73 myelination, which is severely disturbed in preterm infants affected with diffuse white matter injur
77 an be disrupted by perinatal inflammation in preterm infants, although the mechanisms are incompletel
78 ntake and preterm birth among 496 mothers of preterm infants and 5,398 mothers with full-term deliver
79 0 ppm on postnatal days 5 to 14 to high-risk preterm infants and continued for 24 days, appears to be
80 atidylcholine (PC) and choline metabolism in preterm infants and demonstrate the molecular specificit
81 e prevalence of P. jirovecii colonization in preterm infants and its possible association with medica
82 ndicator of long-term health and survival in preterm infants and molds circuit formation, but gaps re
83 ch as respiratory distress syndrome (RDS) in preterm infants and oxidative stress-influenced diseases
84 and metabolic features of growth failure in preterm infants and potentially modifiable targets for i
86 these proteins might aide in development of preterm infants and prevent microbiota-associated disord
87 ometric mean concentrations were compared in preterm infants and the control group of term infants.
89 ize and quantify early foveal development in preterm infants and to compare this development between
91 nt of new guidelines for nutritional care of preterm infants, and 2) develop a targeted research agen
92 ular and imaging data from animal models and preterm infants, and find that microglial expression of
93 f animal protein supplementation in mothers, preterm infants, and term infants/children on birth and
94 grey matter abnormalities frequently seen in preterm infants are associated with increased polygenic
105 The benefits of human milk for hospitalized preterm infants are well documented, but the extent to w
106 , major causes of mortality and morbidity in preterm infants, are reduced in infants fed their own mo
111 ur les Petits Ages Gestationnels), including preterm infants born at <32 wk of gestation in France in
112 rtality or moderate/severe BPD among similar preterm infants born at 28 weeks or younger following NS
113 he Netherlands and Belgium, fecal samples of preterm infants born at a gestational age <=30 weeks wer
114 ulation-based cohort study that included all preterm infants born at less than 29 weeks of gestation
116 ing vs delayed umbilical cord clamping among preterm infants born at less than 32 weeks' gestation, t
117 nary dysplasia than a control emulsion among preterm infants born before 29 weeks of gestation and ma
123 , we measured top-down sensory prediction in preterm infants (born <33 weeks gestation) before infant
124 als published in English, enrolled intubated preterm infants (born <37 weeks' gestation), and reporte
125 Noninferiority randomized clinical trial of preterm infants (born at 23-31 weeks' gestation) from 9
127 cocorticoid therapy reduces mortality in the preterm infant, but evidence suggests off-target adverse
128 l care have greatly improved the survival of preterm infants, but the long-term complications of prem
129 increases the rate of survival of extremely preterm infants, but there are concerns that improved su
130 th factor-1) is markedly decreased in normal preterm infants, but whether IGF-1 treatment can prevent
131 clamping may provide equivalent benefits to preterm infants, but without delaying resuscitation.
132 domination of the fungal communities of some preterm infants by Saccromycetes, specifically Candida,
135 ted by a static in vitro digestion model for preterm infants coupled with intestinal absorption using
136 ut associated cerebral lesions are common in preterm infants currently not regarded as at highest ris
139 of 401 stools from 84 longitudinally sampled preterm infants demonstrates that meropenem, cefotaxime
140 a separate behavioral control confirmed that preterm infants detect pattern violations at the same ra
141 ds given in the first months of life to very preterm infants does not appear to confer any long-term
142 d vaccine had a reduced risk of delivering a preterm infant during times of high influenza virus circ
143 crobiota and resistome of antibiotic-exposed preterm infants during and after hospitalization, and we
144 types of cardio-respiratory events (CRE) in preterm infants during postnatal transition, as well as
145 of a randomized clinical trial of extremely preterm infants, early low-dose hydrocortisone was not a
146 ethods and the prevalence of OCT findings in preterm infants enrolled in BabySTEPS at a single time p
147 Comparison of screened and not screened preterm infants enrolled in the EPIPAGE 2 national prosp
150 ficits in this ability may be the reason why preterm infants experience altered developmental traject
153 e two debilitating disorders that develop in preterm infants exposed to supplemental oxygen to preven
156 in weight gain and head growth between very preterm infants fed human milk compared with infant form
158 opoietin treatment administered to extremely preterm infants from 24 hours after birth through 32 wee
160 reate predictive growth charts for weight in preterm infants from birth till discharge, that took int
164 mized, noninferiority trial, we assigned 564 preterm infants (gestational age, >/=28 weeks 0 days) wi
167 the short-term effects of antibiotics on the preterm infant gut microbiota and resistome persist afte
170 ompared with very preterm infants, extremely preterm infants had thinner RNFL (58.0 +/- 10.7 mum vs 6
172 Fecal samples from term infants, but not preterm infants, had significantly higher levels of S100
175 he antibiotics most commonly administered to preterm infants, have non-uniform effects on species ric
178 is NRCS-A clone is responsible for sepsis in preterm infants in neonatal intensive care units (NICUs)
179 nd reduction of late-onset sepsis of extreme preterm infants in South Wales between 2007 and 2016.
180 s a term-born control group in the Extremely Preterm Infants in Sweden Study (EXPRESS), were examined
181 January 15, 2014, of the national Extremely Preterm Infants in Sweden Study, including preterm child
182 ish the major causes of preterm mortality in preterm infants in the first 28 days of life in Ethiopia
183 ged gestation and improved outcomes for very preterm infants in units that systematically use these o
184 inadequate to meet the requirements of very preterm infants; in addition, intraindividual and interi
185 alysis of IgA binding to fecal bacteria from preterm infants indicated that maternal milk was the pre
186 ow advancement of enteral feeding volumes in preterm infants is associated with a reduced risk of nec
187 er early hydrocortisone therapy in extremely preterm infants is associated with neurodevelopmental im
194 microbiome, including metabolic profiles, in preterm infants <34 weeks of gestation preceding LOS.
196 lymphocytes from HCA-positive and -negative preterm infants matched for gestational age, sex, race,
197 ocosahexaenoic acid (DHA) supplementation of preterm infants may improve outcomes in visual processin
198 across gestation, and in a cohort of n = 64 preterm infants (mean age at birth = 32.0 weeks), we tes
200 amples (n = 517) from full-term (n = 72) and preterm infants (n = 49) at different timepoints over th
202 respiratory failure at birth, most extremely preterm infants now survive, but they often develop chro
204 nd, placebo-controlled phase 3 trial in 1154 preterm infants of 1 or 2 doses of suptavumab, a human m
209 Transfaunation of microbiota from HBM-fed preterm infants or a newly identified and cultured Propi
210 an adequate knowledge of the development of preterm infants' oral feeding skills so as to optimize t
211 ifferences in motor milestone achievement in preterm infants.Our results suggest that differences in
213 e b between 34.7% and 46.2% (40.6% among all preterm infants overall), and pneumococcal serotypes 4,
214 othesis that decreased cord Klotho levels in preterm infants predict increased BPD-PH risk and early
216 hout Bronchopulmonary Dysplasia in Extremely Preterm Infants) randomized clinical trial conducted bet
221 er administration of inhaled nitric oxide to preterm infants requiring positive pressure respiratory
224 commended that nutritional management of the preterm infant should aim to achieve body composition th
226 s and enable early identification of at-risk preterm infants should improve trial design and individu
229 , prospective, observational cohort study of preterm infants stratified according to gestational age
230 create body composition reference curves for preterm infants that approximate the body composition of
232 crobiota and resistome assembly in extremely preterm infants that received early-life antibiotics.
233 and late-preterm (hereafter, "moderate/late preterm") infants, the largest cohort of preterm infants
234 ctice Guidelines for the Nutritional Care of Preterm Infants: The Pre-B Project" is the first phase i
235 eeks to improve vaccine coverage and protect preterm infants.This study assesses the impact of offeri
237 ence charts for total FM and FFM at birth in preterm infants to assist in following AAP guidelines.
238 ing term infants to be assessed at birth and preterm infants to be monitored until they reached term.
242 m (SNP)-based genotypes from a cohort of 272 preterm infants, using Sparse Reduced Rank Regression (s
243 d antibodies were significantly lower in all preterm infants vs term infants, except for pertussis to
245 The prevalence of exclusive breastfeeding in preterm infants was lower than in term infants at 4 mo p
249 elial cells (HUVECs) obtained from extremely preterm infants were associated with risk for BPD or dea
250 Between July 1, 2016, to May 31, 2018, 4919 preterm infants were enrolled in the study and 3852 were
252 n England halved after the policy change and preterm infants were no longer over-represented amongst
253 n a single-center cohort, fecal samples from preterm infants were prospectively collected during the
254 gnancies (78%) resulted in a live birth, two preterm infants were stillborn, and four pregnancies res
255 d controlled trial, 12 hospitalized tube-fed preterm infants were their own control group in comparin
256 easons, is the first alternative for feeding preterm infants when mothers' own milk is unavailable.
257 ins in utero for a significant proportion of preterm infants, which focuses attention on the developm
258 Primary end points were (1) proportion of preterm infants who achieved IgG antibody against vaccin
259 pecially challenging for immature, extremely preterm infants who are typically supported by total par
261 clusions and Relevance: Of the 441 extremely preterm infants who had received active perinatal care,
263 irth in infants with chorioamnionitis and in preterm infants who subsequently went on to develop lung
264 Klotho levels were measured in cord blood of preterm infants who were enrolled in a longitudinal coho
266 on (particularly for proteins and lipids) in preterm infants who were fed their mothers' own milk eit
267 vember 15, 2011, to December 23, 2016, among preterm infants with a gestational age of less than 30 w
268 /kg/d did not further enhance growth of very preterm infants with a median birth weight of 1200 g, wh
269 y proton magnetic spectroscopy ((1)H-MRS) in preterm infants with advancing post-menstrual age (PMA)
270 atent ductus arteriosus (PDA) ligation among preterm infants with adverse neonatal outcomes and neuro
272 sive assessment of pulmonary gas exchange in preterm infants with and without bronchopulmonary dyspla
278 ore diverse and different from that of older preterm infants with established chronic lung disease (b
279 with GA 29-32 weeks without ROP, 13/59 (22%) preterm infants with GA </= 28 weeks without ROP and 14/
280 In this cross-sectional study, 239 former preterm infants with gestational age (GA) </= 32 weeks a
281 med a prospective, longitudinal study of 587 preterm infants with gestational age less than 34 weeks
282 enterocolitis (NEC) is a disease of neonatal preterm infants with high morbidity and mortality that i
284 abolite concentrations are decreased in very preterm infants with moderate-to-severe structural cereb
286 the primary means of respiratory support for preterm infants with respiratory distress has not been p
288 ows us to predict gestational age at scan in preterm infants with root mean squared error 1.41 weeks.
292 vely studied prospectively collected data of preterm infants with surgical NEC who had available rint
295 se the observed increase in the incidence of preterm infants with treatment-demanding ROP during a re
296 , 4/264 (2%) full-term infants, 15/125 (12%) preterm-infants with GA 29-32 weeks without ROP, 13/59 (
297 ent of infants diagnosed with BPD and 34% of preterm infants without BPD had no clinical signs of lat
298 ar values of shift, V . a/Q . , and shunt to preterm infants without bronchopulmonary dysplasia.
299 rolled a geographically-based cohort of very preterm infants without severe brain injury and born bef